The main purpose of this study is to evaluate the efficacy and safety of retatrutide in relieving chronic low back pain in participants who have obesity or overweight. Participation in the study will last about 80 weeks.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
586
Administered SC
Administered SC
Change from Baseline in Pain Intensity Per Numeric Rating Scale
Time frame: Baseline, up to 72 weeks
Percent Change from Baseline in Body Weight
Time frame: Baseline, up to 72 weeks
Number of Participants with Reduction in Pain Intensity Per Numeric Rating Scale
Time frame: Baseline, up to 72 weeks
Number of Participants with Reduction in Body Weight
Time frame: Baseline, up to 72 weeks
Change in Physical Function as Measured by Patient-Reported Outcomes Measurement Information Systems (PROMIS)
Time frame: Baseline, up to 72 weeks
Change in Pain Interference as Measured by PROMIS
Time frame: Baseline, up to 72 weeks
Change in Sleep as Measured by PROMIS
Time frame: Baseline, up to 72 weeks
Change in Patient Reported Health Outcomes as Measured by Medical Outcomes Study 36-item Short Form Health Survey version 2 (SF-36v2)
Time frame: Baseline, up to 72 weeks
Change in Waist Circumference
Time frame: Baseline, up to 72 weeks
Change in Biomarkers of Inflammation as Measured by Blood Test
Time frame: Baseline, up to 72 weeks
Change in Blood Pressure
Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or
CONTACT
Physicians interested in becoming principal investigators please contact
CONTACT
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
MD First Research - Chandler
Chandler, Arizona, United States
RECRUITINGTucson Orthopaedic Institute - North Wyatt Drive
Tucson, Arizona, United States
RECRUITINGArk Clinical Research - Fountain Valley
Fountain Valley, California, United States
RECRUITINGSt Joseph Heritage Healthcare
Fullerton, California, United States
RECRUITINGClinical Research Institute
Los Angeles, California, United States
RECRUITINGArtemis Institute for Clinical Research
San Diego, California, United States
RECRUITINGAlpine Clinical Research Center
Boulder, Colorado, United States
RECRUITINGK2 Medical Research - Daytona Beach
Daytona Beach, Florida, United States
RECRUITINGFlourish Research - Miami, LLC
Miami, Florida, United States
RECRUITINGIMA Clinical Research St. Petersburg
St. Petersburg, Florida, United States
RECRUITING...and 37 more locations
Time frame: Baseline, up to 72 weeks
Change in Glycemic Control
Time frame: Baseline, up to 72 weeks
Percent Change in Total Cholesterol
Time frame: Baseline, up to 72 weeks
Percent Change in Urine Albumin-to-Creatinine Ratio (UACR)
Time frame: Baseline, up to 72 weeks